Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Doug Case

Showing results (1-10 of 56) with videos related to

Pageof 6
Sort By:
Clinical Trials (London, England)|June 19, 2008
Commentary on 'designing phase II studies in cancer with time-to-event endpoints'Doug Case, Tim Morgan
Thrombosis and Haemostasis|April 2, 2003
Inappropriate use of positive predictive value in describing the rapid collagen binding assay for von Willebrand factor cleaving proteaseMary Ann Knovich, Doug Case, John Owen
Gynecologic Oncology|December 13, 2002
Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinicBrigitte E Miller, Barbara Pittman, Doug Case, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 9, 2017
Vascular Access in Critically Ill Pediatric Patients With ObesityElizabeth E Halvorson, Doug Case, Joseph A Skelton, et al.
Applied Clinical Informatics|January 10, 2019
The Reach and Feasibility of an Interactive Lung Cancer Screening Decision Aid Delivered by Patient PortalAjay Dharod, Christina Bellinger, Kristie Foley, et al.
Lung Cancer (Amsterdam, Netherlands)|October 20, 2006
Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancerAntonius A Miller, Amal Al Omari, Daryl J Murry, et al.
Toxins|May 19, 2012
Mutagenicity of ochratoxin A and its hydroquinone metabolite in the SupF gene of the mutation reporter plasmid Ps189Steven A Akman, Marissa Adams, Doug Case, et al.
Annals of Surgical Oncology|June 23, 2010
Sentinel lymph node intraoperative imprint cytology in patients with breast cancer-costly or cost effective?Jan P Kamiński, Doug Case, Marissa Howard-McNatt, et al.
The American Surgeon|July 11, 2003
Effect of massage technique on sentinel lymph node mapping for cancer of the breastGeorgia Haynes, Diane Garske, Doug Case, et al.
Clinical Oral Investigations|March 6, 2014
Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumorsSusan Mirlohi, Susan E Duncan, Michele Harmon, et al.
Pageof 6

Showing results (1-10 of 56) with videos related to

Sort By:
Pageof 6
Clinical Trials (London, England)|June 19, 2008
Commentary on 'designing phase II studies in cancer with time-to-event endpoints'Doug Case, Tim Morgan
Thrombosis and Haemostasis|April 2, 2003
Inappropriate use of positive predictive value in describing the rapid collagen binding assay for von Willebrand factor cleaving proteaseMary Ann Knovich, Doug Case, John Owen
Gynecologic Oncology|December 13, 2002
Quality of life after treatment for gynecologic malignancies: a pilot study in an outpatient clinicBrigitte E Miller, Barbara Pittman, Doug Case, et al.
Pediatric Critical Care Medicine : a Journal of the Society of Critical Care Medicine and the World Federation of Pediatric Intensive and Critical Care Societies|November 9, 2017
Vascular Access in Critically Ill Pediatric Patients With ObesityElizabeth E Halvorson, Doug Case, Joseph A Skelton, et al.
Applied Clinical Informatics|January 10, 2019
The Reach and Feasibility of an Interactive Lung Cancer Screening Decision Aid Delivered by Patient PortalAjay Dharod, Christina Bellinger, Kristie Foley, et al.
Lung Cancer (Amsterdam, Netherlands)|October 20, 2006
Phase I and pharmacologic study of sequential topotecan-carboplatin-etoposide in patients with extensive stage small cell lung cancerAntonius A Miller, Amal Al Omari, Daryl J Murry, et al.
Toxins|May 19, 2012
Mutagenicity of ochratoxin A and its hydroquinone metabolite in the SupF gene of the mutation reporter plasmid Ps189Steven A Akman, Marissa Adams, Doug Case, et al.
Annals of Surgical Oncology|June 23, 2010
Sentinel lymph node intraoperative imprint cytology in patients with breast cancer-costly or cost effective?Jan P Kamiński, Doug Case, Marissa Howard-McNatt, et al.
The American Surgeon|July 11, 2003
Effect of massage technique on sentinel lymph node mapping for cancer of the breastGeorgia Haynes, Diane Garske, Doug Case, et al.
Clinical Oral Investigations|March 6, 2014
Analysis of salivary fluid and chemosensory functions in patients treated for primary malignant brain tumorsSusan Mirlohi, Susan E Duncan, Michele Harmon, et al.
Pageof 6